Three major driving forces continue the trend of local state-owned assets acquiring listed companies

華爾街見聞
2025.08.14 22:31
今年以來，地方國資掀起了收購上市公司熱潮，產業併購基金和國資創投平台成為主力軍。近日，上海國資旗下上海生物醫藥併購基金併購 “開單”，其控股的萬可欣生物擬斥資 18.51 億元戰略入主康華生物，還擬通過協議轉讓方式收購微創醫療股份，成為微創醫療的戰略股東。湖北省級投資平台長江產業投資集團年初控股凱龍股份後，6 月又將台基股份納入旗下。安徽馬鞍山國資江東產投也在 7 月入主藍黛科技。 多位業內人士表示，地方國資入主上市公司有三大動因。一是在政策鼓勵背景下，開展一批高質量併購是各地國企改革深化提升行動的重要舉措；二是通過併購招商，將上市公司作為精準招商引資的新槓桿；三是推進相關產業整合與升級，打造重點領域龍頭企業。（證券時報）
Source: 華爾街見聞 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.